8049 Cisplatin-based combination chemotherapy (CTX) consisting of docetaxel and cisplatin (DP) is still effective for patients with relapsed ovarian carcinoma (ROC) resistant or refractory to carboplatin-based CTX (TC: taxol/carboplatin)